RedHill Biopharma (RDHL) Liabilities and Shareholders Equity (2011 - 2026)
RedHill Biopharma's Liabilities and Shareholders Equity came in at $25.35 million for the quarter ended Dec 31, 2025, up 40.5% from $18.04 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
Going back to the quarter ended Dec 31, 2011, RedHill Biopharma's Liabilities and Shareholders Equity data covers 49 quarters.
- Liabilities and Shareholders Equity carries a five-year compound annual growth rate of -32.5% (years ended Dec 2020 to Dec 2025).
- Going back by year, Liabilities and Shareholders Equity was $18.04 million in the year ended Dec 31, 2024 (-21.7%), $23.05 million in the year ended Dec 31, 2023 (-85.5%), $158.87 million in the year ended Dec 31, 2022 (-12.3%) and $181.19 million in the year ended Dec 31, 2021 (+0.5%).
- The figure for the quarter ended Dec 31, 2025 represents the highest quarterly Liabilities and Shareholders Equity since the quarter ended Jun 30, 2023.
- Year-over-year, Liabilities and Shareholders Equity increased in 1 of the last four quarters, with an average decline of 8.7%.
- The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in the quarter ended Mar 31, 2021 (growth of 53.4%), and the weakest in the quarter ended Dec 31, 2023 (a decline of 85.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | RedHill Biopharma | 7.09 Mn | 7.09 Mn | - | 26.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.27 Mn |
| Dec 31, 2025 | 25.35 Mn |
| Jun 30, 2025 | 18.38 Mn |
| Dec 31, 2024 | 18.04 Mn |
| Jun 30, 2024 | 22.02 Mn |
| Dec 31, 2023 | 23.05 Mn |
| Jun 30, 2023 | 35.04 Mn |
| Mar 31, 2023 | 58.83 Mn |
| Dec 31, 2022 | 158.87 Mn |
| Sep 30, 2022 | 157.19 Mn |
| Jun 30, 2022 | 167.97 Mn |
| Mar 31, 2022 | 167.05 Mn |
| Dec 31, 2021 | 181.19 Mn |
| Sep 30, 2021 | 186.34 Mn |
| Jun 30, 2021 | 203.67 Mn |
| Mar 31, 2021 | 220.12 Mn |
| Dec 31, 2020 | 180.24 Mn |
| Sep 30, 2020 | 168.98 Mn |
| Jun 30, 2020 | 166.37 Mn |
| Mar 31, 2020 | 143.48 Mn |
API Access
RedHill Biopharma Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();